✦ LIBER ✦

Malignant tumors of the testis: Analysis of treatment results and sites and causes of failure

✍ Scribed by Jeanne M. Quivey; Karen K. Fu; Karen A. Herzog; Jerome M. Weiss; Theodore L. Phillips

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 576 KB
Volume: 39
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197703)39:3<1247::aid-cncr2820390334>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carcinoma of the major and minor salivar

Carcinoma of the major and minor salivary glands. Analysis of treatment results and sites and causes of failures

✍ Karen K. Fu; Steven A. Leibel; Michael L. Levine; Lawrence M. Friedlander; Roger 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 688 KB

Endometrial carcinoma: Causes of death a

Endometrial carcinoma: Causes of death and sites of treatment failure

✍ Mahmood Yoonessi; David G. Anderson; George W. Morley 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

Results of treatment of malignant tumors

Results of treatment of malignant tumors with ftorafur

✍ N. G. Blokhina; E. K. Vozny; A. M. Garin 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 2 views

Carcinoma of the pyriform sinus. An anal

Carcinoma of the pyriform sinus. An analysis of treatment results and patterns of failure

✍ J. E. Marks; B. Kurnik; W. E. Powers; J. H. Ogura 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

Hypophysectomy in the treatment of malig

Hypophysectomy in the treatment of malignant tumors

✍ Rolf Luft; Herbert Olivecrona 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 2 views

Combined surgery and chemotherapy in the

Combined surgery and chemotherapy in the treatment of malignant tumors

✍ W. Denk; K. Karrer 📂 Article 📅 1961 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

ESPITE great advances in medicine, the re-D sults of treatment of malignant tumors remains unsatisfactory. Development of chemotherapy of inoperable malignant tumors is still in a beginning state. T h e high mortality rate resulting from secondary growth-recurrence and metastases-in patients having